Prostate Cancer Utilities and Cost-Effectiveness Analysis

Completed

• Conditions: Prostate Cancer
• Interventions: Behavioral: Survey, interview; Behavioral: patient utility scores (i.e. patient preference weights)

• Registration Number: NCT00203918
• Lead Sponsor: University of Chicago

Brief Summary

The purpose of this study is to help doctors and patients make better decisions about prostate cancer treatment. This research is being done because we do not know how patient preferences for health states related to prostate cancer affect the final treatment decision.

Detailed Description

The goal of this project is to incorporate patients' preferences into a previously developed prostate cancer treatment decision-model and to understand the implications for doing so for cost-effectiveness analysis. To do this, it is first necessary to obtain patient utility scores (i.e., patient preference weights). To do this we will perform a survey of patients visiting the urology clinic to undergo prostate biopsies to validate a method of utility assessment, and understand the patients' individual evaluations of treatment-related health studies. We will also ask patients questions relating to their anxiety levels concerning the possible diagnosis of prostate cancer.

Study Timeline

• Study Start: 2004-01
• Study First Submitted: 2005-09-12
• Study First Submitted QC: 2005-09-12
• Study First Posted: 2005-09-20
• Primary Completion: 2011-02
• Study Completion: 2013-02
• Status Verified: 2017-08
• Last Update Submitted: 2017-08-28
• Last Update Posted: 2017-08-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 481

Inclusion Criteria

• Patients undergoing prostate biopsy

Exclusion Criteria

• Women and children will be excluded, as prostate cancer occurs in men only
• Diagnosis of dementia

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Prostate biopsies	patient utility scores (i.e. patient preference weights)	Males undergoing prostate biopsies
Prostate biopsies	Survey, interview	Males undergoing prostate biopsies

Primary Outcome Measures

Name	Time	Method
Utility scores for treatment outcomes	90 days after enrollment	Patient utility scores (i.e. patient preference weights) are calculated using survery data will determine which prostate cancer treatment would be most cost-effective for each subject. Patients will be contacted by phone and patient records will be reviewed 90 days after the survey has been completed to determine whether this data reflects actual treatment decisions.

Secondary Outcome Measures

Name	Time	Method
Anxiety levels	90 days after enrollment	We will also ask patients questions relating to their anxiety levels concerning the possible diagnosis of prostate cancer.

Trial Locations

Locations (1)

The University of Chicago; 🇺🇸 Chicago, Illinois, United States